Mesoblast (MESO) Asset Utilization Ratio (2015 - 2023)
Mesoblast (MESO) posted Asset Utilization Ratio of 0.01 for Q2 2023, down 4.63% sequentially from 0.01 in Q1 2023, and down 18.76% YoY from 0.02 in Q2 2022.
Mesoblast (MESO) Asset Utilization Ratio (2015 - 2023) Analysis & Trends
Mesoblast has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.01 in Q2 2023.
- Quarterly Asset Utilization Ratio fell 18.76% year-over-year to 0.01 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.01 (down 18.76% YoY) and the FY2025 annual result came in at 0.02, up 168.29% from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q2 2023 per MESO's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.05 in Q2 2020 and troughed at 0.01 in Q1 2019.
- A 5-year average of 0.02 and a median of 0.01 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2020 and 2021: Asset Utilization Ratio jumped 473.41% in 2020, then plunged 78.4% in 2021.
- Over 5 years, Asset Utilization Ratio stood at 0.01 in 2019, then soared by 346.56% to 0.05 in 2020, then plunged by 69.47% to 0.01 in 2021, then fell by 8.44% to 0.01 in 2022, then fell by 2.99% to 0.01 in 2023.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |